Investing
1491 Articles
February 29, 2016: Markets opened lower on Monday before rising to intra-day highs at around noon, and then dipping to…
With investors looking for safety and dividends for total return, the big pharmaceutical stocks are just the ticket, and these…
February 26, 2016: Markets opened higher on Friday on rising oil prices in Asia and Europe which turned into lower…
For the long haul, these three stock should provide a much better avenue for total return and continue to increase…
The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…
The most shorted stock traded on the New York Stock Exchange — Chesapeake Energy — bucked the short interest trend…
Pfizer has announced that the FDA approved Xeljanz XR (tofacitinib citrate) extended-release tablets for the once-daily treatment of moderate to…
These stocks make good sense for long-term patient investors that have a growth and income total return bias in their…
In a new research report, Jefferies shuffles some of the pharmaceutical stocks in its coverage universe and a beaten-down dividend…
For worried investors that need an income stream, all these top stocks make good sense for growth and income portfolios.
Pfizer has announced that it had settled outstanding claims for a total of more than $784 million related to calculated…
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside…
The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…
Among the six most heavily shorted stocks traded on the New York Stock Exchange, short sellers continued to pile on…
Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating…
Our top personal finance-related articles today. Your wallet will thank you later.